Skip to main content
Signal8

Soni Manmeet Singh

SEC insider (Form 3/4/5 filer). CIK 0001569769. Director at PULSE BIOSCIENCES, INC. (PLSE) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in MIAMI, FL.

Companies Soni Manmeet Singh has filed insider reports for

  • PULSE BIOSCIENCES, INC. (PLSE): Director
  • Summit Therapeutics Inc. (SMMT): Director, Officer, COO and CFO
Soni Manmeet Singh profile photo

Soni Manmeet Singh

CIK: 0001569769

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PULSE BIOSCIENCES, INC. logo
PLSE

PULSE BIOSCIENCES, INC.

Director
Summit Therapeutics Inc. logo
SMMT

Summit Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • PULSE BIOSCIENCES, INC. logo
    PLSE

    PULSE BIOSCIENCES, INC.

    Jun 11, 2026
    Award

    Stock Option (right to buy)

    Direct
    30K shares-
  • Summit Therapeutics Inc. logo
    SMMT

    Summit Therapeutics Inc.

    Jun 4, 2026
    Purchase
    Direct
    25K shares at avg. $14.46$362K
  • Summit Therapeutics Inc. logo
    SMMT

    Summit Therapeutics Inc.

    Jun 4, 2026
    Purchase
    Direct
    25K shares at avg. $14.43$361K
  • Summit Therapeutics Inc. logo
    SMMT

    Summit Therapeutics Inc.

    Oct 21, 2025
    Award
    Direct
    53.4K shares at avg. $18.74$1000K
  • PULSE BIOSCIENCES, INC. logo
    PLSE

    PULSE BIOSCIENCES, INC.

    Aug 15, 2025
    Award

    Stock Option (right to buy)

    Direct
    30K shares-
  • Summit Therapeutics Inc. logo
    SMMT

    Summit Therapeutics Inc.

    Apr 29, 2025
    Award

    Stock Option (right to buy)

    Direct
    11.2M shares-
  • Summit Therapeutics Inc. logo
    SMMT

    Summit Therapeutics Inc.

    Sep 11, 2024
    Award
    Direct
    44.1K shares at avg. $22.70$1000K

1-7 of 7